News & events | Fujirebio

United States of America

Choose your country

Select your country

Did you know? Fujirebio and Covid-19

In a reply to the Covid-19 pandemic impacting the world since early 2020, Fujirebio plays an important role as a healthcare partner, offering various testing solutions that are used across the world today to support fast and trustworthy diagnosis.

Upcoming events

Lentevergadering Ceci n’est pas Covid - Vlaamse Vereniging Voor Neurologie (VVN)

May 8, 2021 - May 8, 2021

Virtual event ,

More info and meet us there

CMEF 2021 - China International Medical Equipment Fair

May 13, 2021 - May 16, 2021

More info and meet us there

5ème soirée scientifique de l'AABC

May 27, 2021 - May 27, 2021

Wavre or digital ,

More info and meet us there

See all upcoming events

Latest news

Statement on the impact of coronavirus disease Covid-19 on our operations

The novel coronavirus disease Covid-19 first reported in late 2019 has spread worldwide. At Fujirebio Europe’s Belgian facilities, we are...

Read more

OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform

Gent, Belgium, December 8, 2020 – OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they...

Read more

Fujirebio Europe and CENTOGENE enter partnership to provide rapid and high-quality preventive SARS-CoV-2 antigen testing

Gent, Belgium, Cambridge, Mass., USA, and Rostock and Berlin, Germany – November 9, 2020: Fujirebio Europe and Centogene N.V. (Nasdaq: CNTG)...

Read more

Fujirebio Europe enters an agreement with ADx NeuroSciences for the commercialization of novel biomarkers

Fujirebio Europe and ADx NeuroSciences announced today that they have concluded an agreement related to the development and...

Read more

Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 antigen assay and the rapid antigen device ESPLINE® SARS-CoV-2

With these new products Fujirebio further positions itself as a leading global provider of immunoassay testing solutions to the IVD industry...

Read more

Fujirebio Europe launches the Lumipulse® G Aldosterone and Renin assays for fully automated quantitative determination of aldosterone and active renin

Fujirebio Europe announces the release of the Lumipulse G Aldosterone and Renin assays for the fully automated quantitative determination of...

Read more

site by D'M&S

Close